Select Medical Holdings has reported attributable net income of $46.27m in the fourth quarter (Q4) of 2023, a 68.2% increase from $27.5m in the same period of 2022. 

The Pennsylvania-based healthcare company’s earnings per common share stood at $0.36 in Q4 2023, versus $0.22 in Q4 2022. 

Its revenue for the October-December 2023 quarter was $1.66bn, a 4.9% growth from $1.58bn in the prior year.  

Segment-wise, revenue totalled $567.13m for Critical Illness Recovery Hospital business in the reported quarter, up 0.9% from $561.88m in Q4 2022.  

The Rehabilitation Hospital segment logged 9.4% revenue growth to $260.16m, compared with $237.85m in Q4 2022 while the Outpatient Rehabilitation segment’s revenue increased 6.1% to $298.23m from $281.09m.  

The company’s Concentra business recorded a 6.2% revenue increase to $440.74m compared with $415m in Q4 2022.  

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Income from operations saw a boost of 31.5%, amounting to $114.25m for Q4 2023. 

Adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) for Q4 2023 came in at $180.05m, representing an increase of 20.9% from $148.91m in Q4 2022. 

For the full year, net income was $299.73m, a 51.4% surge from $198.02m for the prior year, while revenue rose 5.2% to $6.66bn from $6.33bn.  

Income from operations for 2023 rose 37.6% to $554.87m from $403.28m in the previous year, and adjusted EBITDA increased 24.8% year-on-year to $807.42m.